Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases

C Huynh, J Ryu, J Lee, A Inoki, K Inoki - Nature Reviews Nephrology, 2023 - nature.com
Nutrients such as glucose, amino acids and lipids are fundamental sources for the
maintenance of essential cellular processes and homeostasis in all organisms. The nutrient …

Insights into autosomal dominant polycystic kidney disease from genetic studies

MB Lanktree, A Haghighi, I di Bari… - Clinical journal of the …, 2021 - journals.lww.com
Autosomal dominant polycystic kidney disease is the most common monogenic cause of
ESKD. Genetic studies from patients and animal models have informed disease …

Renal plasticity revealed through reversal of polycystic kidney disease in mice

K Dong, C Zhang, X Tian, D Coman, F Hyder, M Ma… - Nature …, 2021 - nature.com
Initiation of cyst formation in autosomal dominant polycystic kidney disease (ADPKD) occurs
when kidney tubule cells are rendered null for either PKD1 or PKD2 by somatic 'second …

[HTML][HTML] Ketosis ameliorates renal cyst growth in polycystic kidney disease

JA Torres, SL Kruger, C Broderick, T Amarlkhagva… - Cell metabolism, 2019 - cell.com
Mild reduction in food intake was recently shown to slow polycystic kidney disease (PKD)
progression in mouse models, but whether the effect was due to solely reduced calories or …

[HTML][HTML] Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD—a randomized controlled trial

S Cukoski, CH Lindemann, S Arjune, P Todorova… - Cell Reports …, 2023 - cell.com
Ketogenic dietary interventions (KDIs) are beneficial in animal models of autosomal-
dominant polycystic kidney disease (ADPKD). KETO-ADPKD, an exploratory, randomized …

[HTML][HTML] Polycystic kidney disease, autosomal dominant

PC Harris, VE Torres - 2018 - europepmc.org
Autosomal dominant polycystic kidney disease (ADPKD) is generally a late-onset
multisystem disorder characterized by bilateral kidney cysts, liver cysts, and an increased …

Inhaled silica nanoparticles cause chronic kidney disease in rats

F Sasai, KL Rogers, DJ Orlicky… - American Journal …, 2022 - journals.physiology.org
Silica nanoparticles (SiNPs) released during the burning of sugarcane have been
postulated to have a role in chronic kidney disease of unknown etiology. We tested the …

Ketogenic dietary interventions in autosomal dominant polycystic kidney disease—a retrospective case series study: first insights into feasibility, safety and effects

S Strubl, S Oehm, JA Torres, F Grundmann… - Clinical kidney …, 2022 - academic.oup.com
Background Our laboratory published the first evidence that nutritional ketosis, induced by a
ketogenic diet (KD) or time-restricted diet (TRD), ameliorates disease progression in …

Short-term dapagliflozin administration in autosomal dominant polycystic kidney disease—a retrospective single-arm case series study

F Morioka, S Nakatani, H Uedono, A Tsuda… - Journal of Clinical …, 2023 - mdpi.com
Treatment with sodium-glucose cotransporter-2 (SGLT2) inhibitors may have pleiotropic and
beneficial effects in terms of ameliorating of risk factors for the progression of autosomal …

[HTML][HTML] L-ergothioneine and its combination with metformin attenuates renal dysfunction in type-2 diabetic rat model by activating Nrf2 antioxidant pathway

A Dare, ML Channa, A Nadar - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Abstract L-ergothioneine (L-egt) is a bioactive compound recently approved by the food and
drug administration as a supplement. L-egt exerts potent cyto-protective, antioxidant and anti …